Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00563264 · ClinicalTrials.gov registry record · NA
KAN-DO: A Family-based Intervention to Prevent Childhood Obesity
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 832
- Enrollment target
NCT00563264: Completed NA study, sponsored by Duke University.
NCT00563264 is a NA study that has completed, run by Duke University. The registered enrollment target is 832 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00563264, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 832 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of an intervention (KAN-DO: Kids \& Adults Now - Defeat Obesity) encouraging postpartum mothers and their preschool-aged children to work together to promote healthy eating, increase physical activity, and reduce sedentary behaviors. Via instruction in parenting skills and behavior change strategies, the goal is relative weight maintenance in children of healthy weight, and relative weight reduction in overweight children. The intervention will focus on a child (2-5 years of age) and his or her overweight or obese mother, who has just delivered a second or subsequent baby.
Interventions
- BEHAVIORAL KAN-DO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 832 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT00563264 record still lists
NCT00563264 is an interventional study that assigns participants to a tested intervention. The registered 832 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 1 intervention - of which KAN-DO is the first listed.
NCT00563264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00563264 about?
NCT00563264 is a clinical study titled "KAN-DO: A Family-based Intervention to Prevent Childhood Obesity". The purpose of this study is to evaluate the efficacy of an intervention (KAN-DO: Kids \& Adults Now - Defeat Obesity) encouraging postpartum mothers and their preschool-aged children to work together to promote healthy eating, increase physical activity, and reduce sedentary behaviors. Via instruct...
What is the current status of trial NCT00563264?
This trial is currently completed. It is a NA study. The enrollment target is 832 participants. The study started on 2007-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00563264?
The interventions under investigation include: KAN-DO (BEHAVIORAL).
Who is sponsoring clinical trial NCT00563264?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00563264's enrollment target sits among peer trials
832 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia